EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant Nanocarrier Strategies

André E Nel iD, Lijia Luo iD, Yu-Pei Liao iD, Xiang Wang iD

ACS Nano · 09.12.2025 · 19 (48) · 40733-40745

DOI: 10.1021/acsnano.5c14753 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Nano, online erschienen am 22.11.2025. Verfasst von André E Nel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of NanoMedicine, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California 90095, United St…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Nanoparticles, Adjuvants, Immunologic, RNA, Messenger. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, U.S. Public Health Service, Marlin Miller, Jr. Family Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsNanoparticlesAdjuvants, ImmunologicRNA, MessengerAntigens, NeoplasmCancer VaccinesCarcinoma, Pancreatic DuctalAnimalsHumansMiceTumor MicroenvironmentImmunotherapy

Stichwörter der Autor:innen

immune adjuvant nanocarrierimmune toleranceimmunotherapylipid nanoparticlemRNApancreatic ductal adenocarcinoma (PDAC)reprogrammingtumor microenvironment

Substanzen

Adjuvants, ImmunologicRNA, MessengerAntigens, NeoplasmCancer Vaccines

Autor:innen und Institutionen

  • Division of NanoMedicine, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California 90095, United States.
  • California NanoSystems Institute, University of California, Los Angeles, California 90095, United States.
  • Division of NanoMedicine, California Nano Systems Institute, University of California, Los Angeles, California 90095, United States.

ORCID-Profile: André E Nel, Lijia Luo, Yu-Pei Liao, Xiang Wang

Förderung

  • NCI NIH HHS
  • U.S. Public Health Service
  • Marlin Miller, Jr. Family Foundation

Zitieren

APA

Nel, A. E., Luo, L., Liao, Y. P., & Wang, X. (2025). Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant Nanocarrier Strategies. ACS Nano, 19(48), 40733-40745. https://doi.org/10.1021/acsnano.5c14753

Vancouver

Nel AE, Luo L, Liao YP, Wang X. Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant Nanocarrier Strategies. ACS Nano. 2025;19(48):40733-40745. doi:10.1021/acsnano.5c14753

BibTeX
@article{Nel2025,
  author = {Nel, André E and Luo, Lijia and Liao, Yu-Pei and Wang, Xiang},
  title = {Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant Nanocarrier Strategies},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {48},
  pages = {40733--40745},
  doi = {10.1021/acsnano.5c14753}
}
Kostenlos starten →